NEXT BIOMETRICS GROUP AS (NEXT.OL) Stock Analyst Earnings Estimates
OSL:NEXT - Euronext Oslo - NO0010629108 - Common Stock - Currency: NOK
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 48.292M -4.85% | 34.383M -28.80% | 71.959M 109.29% | |
| EBITDA YoY % growth | -40.893M 20.10% | -58.209M -42.34% | -34.694M 40.40% | |
| EBIT YoY % growth | -48.122M 17.39% | -65.277M -35.65% | -40.088M 38.59% | |
| Operating Margin | -99.65% | -189.85% | -55.71% | |
| EPS YoY % growth | -0.51 18.03% | N/A 50.00% | N/A |
All data in NOK
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in NOK
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | 84.31% | -0.02 | % | |
| Q3 2023 Q2Q % growth | 57.50% | -0.05 | % | |
| Q2 2023 Q2Q % growth | 18.40% | -0.08 | % | |
| Q1 2023 Q2Q % growth | -0.16 | -0.11 | -0.05 | -42.60% |
| Q4 2022 Q2Q % growth | -0.13 40.91% | -0.12 | -0.01 | -6.21% |
| Q3 2022 Q2Q % growth | -0.12 26.47% | -0.05 | -0.07 | -135.29% |
| Q2 2022 Q2Q % growth | -0.10 45.53% | -0.08 | -0.02 | -22.55% |
| Q1 2022 Q2Q % growth | -0.16 -12.04% | -0.11 | -0.05 | -42.60% |
| Q4 2021 Q2Q % growth | -0.22 | -0.14 | -0.08 | -54.06% |
| Q3 2019 Q2Q % growth | -0.74 | -0.58 | -0.16 | -27.45% |
| Q2 2019 Q2Q % growth | -0.81 | -0.68 | -0.14 | -20.45% |
| Q1 2019 Q2Q % growth | -1.40 | -0.87 | -0.53 | -61.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 13.261M -7.21% | % | ||
| Q3 2024 Q2Q % growth | 27.576M 361.21% | % | ||
| Q2 2024 Q2Q % growth | 18.319M 150.74% | % | ||
| Q1 2024 Q2Q % growth | 12.804M 88.10% | % | ||
| Q4 2023 Q2Q % growth | 14.291M 18.85% | % | ||
| Q3 2023 Q2Q % growth | 5.979M -58.54% | % | ||
| Q2 2023 Q2Q % growth | 7.306M -37.51% | % | ||
| Q1 2023 Q2Q % growth | 6.807M -32.98% | % | ||
| Q4 2022 Q2Q % growth | 12.024M -12.23% | 16.32M | -4.296M | -26.32% |
| Q3 2022 Q2Q % growth | 14.421M 15.95% | % | ||
| Q2 2022 Q2Q % growth | 11.691M 10.91% | % | ||
| Q1 2022 Q2Q % growth | 10.156M -27.86% | % | ||
| Q4 2021 Q2Q % growth | 13.699M 55.79% | 16.32M | -2.621M | -16.06% |
| Q3 2021 Q2Q % growth | 12.437M -18.33% | 9.18M | 3.257M | 35.48% |
| Q2 2021 Q2Q % growth | 10.541M -22.65% | 11.22M | -679K | -6.05% |
| Q1 2021 Q2Q % growth | 14.078M -31.27% | 14.28M | -202K | -1.41% |
| Q4 2020 Q2Q % growth | 8.793M -4.79% | % | ||
| Q3 2020 Q2Q % growth | 15.229M -13.57% | % | ||
| Q2 2020 Q2Q % growth | 13.628M -54.70% | % | ||
| Q1 2020 Q2Q % growth | 20.484M -25.51% | % | ||
| Q3 2019 Q2Q % growth | 17.621M | 29.58M | -11.959M | -40.43% |
| Q2 2019 Q2Q % growth | 30.082M | 25.5M | 4.582M | 17.97% |
| Q1 2019 Q2Q % growth | 27.498M | 31.62M | -4.122M | -13.04% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |